Search results
Results from the WOW.Com Content Network
The See Clearly Method was an eye-exercise program that was marketed as an alternative to the use of glasses, contact lenses, and eye surgery to improve vision. Sales were halted by legal action in 2006. The method is not supported by basic science, and no research studies were conducted prior to marketing.
Empagliflozin, sold under the brand name Jardiance (/ ˈ dʒ ɑːr d i ə n s / JAR-dee-əns), among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. [12] [2] [14] It is taken by mouth. [2]
The Bates method is an ineffective and potentially dangerous alternative therapy aimed at improving eyesight.Eye-care physician William Horatio Bates (1860–1931) held the erroneous belief that the extraocular muscles caused changes in focus and that "mental strain" caused abnormal action of these muscles; hence he believed that relieving such "strain" would cure defective vision.
The eye exercises used in vision therapy can generally be divided into two groups: those employed for "strabismic" outcomes and those employed for "non-strabismic" outcomes, to improve eye health. Ophthalmologists and orthoptists do not endorse these exercises as having clinically significant validity for improvements in vision.
An ocular manifestation of a systemic disease is an eye condition that directly or indirectly results from a disease process in another part of the body. There are many diseases known to cause ocular or visual changes.
Regular marijuana use may affect how quickly a person processes things in front of them, according to a study published in the journal JAMA Ophthalmology.
Bates graduated A.B. from Cornell University in 1881 and received his medical degree at Columbia University's College of Physicians and Surgeons in 1885. [3] He formulated a theory about vision health, and published the book Perfect Sight Without Glasses in 1920, and the magazine Better Eyesight from 1919 to 1930.
The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include SGLT2 inhibitors as a first line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease, cardiovascular disease or heart failure.